Top Markets
Coin of the day
General Biologicals Corporation General Biologicals Corporation

General Biologicals Corporation

4117
주식 순위 #29236
General Biologicals Corporation (GBC) is a company dedicated to the research,... General Biologicals Corporation (GBC) is a company dedicated to the research, development, production, and global commercialization of in-vitro diagnostic (IVD) solutions, operating extensively both within Taiwan and internationally. The company's core diagnostic offerings include advanced ELISA and chemiluminescence immunoassays, molecular and cellular diagnostic platforms, and rapid point-of-care testing (POCT) systems. Its diverse portfolio further encompasses COVID-19 related solutions, digital pathology, and contract development manufacturing organization (CDMO) services. Additionally, GBC provides essential blood screening services for detecting hepatitis and HIV, alongside crucial biomaterials such as antibody preparations and human plasma. Venturing beyond diagnostics, the company also markets a line of oral care products under its proprietary 'oh care' brand. These diagnostic systems are primarily utilized by clinics and laboratories. Founded in 1973, General Biologicals Corporation is headquartered in Hsinchu City, Taiwan.
주가
$0.31640033
시가총액
$22.25M
변동 (1일)
-3.40%
변동 (1년)
-36.80%
국가
TW
거래 General Biologicals Corporation (4117)

카테고리

General Biologicals Corporation (4117)의 주가 이력
최고 종가: $0.33 (2026-08-01 기준)

최저 종가: $0.23 (2007-10-01 기준)
General Biologicals Corporation의 주가 이력 (2007 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -10.53%
2025 -24.42%
2024 -37.38%
2023 8.75%
2022 -38.49%
2021 -29.29%
2020 406.12%
2019 -13.05%
2018 -17.17%
2017 -20.01%
2016 -28.29%
2015 -1.71%
2014 -19.23%
2013 373.53%
2012 22.78%
2011 -1.29%
2010 8.02%
2009 1.10%
2008 -21.85%
2007 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$236.47 -4.50%
IE
$15.74 -12.71%
CN
$535.31 8.48%
CH
$169.07 -11.34%
CH
$2.28 -30.67%
CN